Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

D Russell-Jones, A Vaag, O Schmitz, B K Sethi, N Lalic, S Antic, M Zdravkovic, G M Ravn, R Simó, Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group

    670 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences